Form 8-K - Current report:
SEC Accession No. 0001193125-25-140731
Filing Date
2025-06-13
Accepted
2025-06-13 16:06:01
Documents
14
Period of Report
2025-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d58708d8k.htm   iXBRL 8-K 40220
2 EX-99.1 d58708dex991.htm EX-99.1 11777
6 GRAPHIC g58708g0613210051491.jpg GRAPHIC 2458
  Complete submission text file 0001193125-25-140731.txt   177438

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alec-20250609.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20250609_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20250609_pre.xml EX-101.PRE 11254
16 EXTRACTED XBRL INSTANCE DOCUMENT d58708d8k_htm.xml XML 3614
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 251046510
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)